HealthVerity Launches taXonomy Pathways to Enhance Patient Data Insights Across Healthcare

HealthVerity Introduces taXonomy Pathways



Date: October 7, 2025
Location: Philadelphia

HealthVerity, recognized as the leader in real-world data (RWD) technologies, has launched a new framework named taXonomy Pathways. This innovative solution is designed to merge various sources of patient data including closed payer claims, lab results, and electronic health records (EHR), enhancing researchers' ability to close gaps in evidence across the healthcare sector. With this launch, HealthVerity aims to streamline the process of obtaining research-ready datasets tailored to specific therapeutic areas.

A Comprehensive Approach to Patient Insights



What sets taXonomy Pathways apart is its ability to draw from the nation's largest closed payer claims database. This encompasses hundreds of payers and spans nine years of adjudicated history, covering over 300 million patients across different insurance types. The taXonomy data model integrates medical and pharmacy claims from multiple payers into a cohesive relational dataset. This simplification allows research teams to quickly become operational and translate study protocols into meaningful analyses.

Furthermore, the framework extends beyond mere claims data, incorporating unique patient insights derived from lab results and EHR, such as physician notes. This depth of information enriches the understanding of patient experiences and treatment pathways, especially in chronic conditions or complex diseases.

Monitoring Disease Progression



For patients with diabetes and obesity, taXonomy Pathways utilizes metrics like BMI, HbA1c levels, weight, blood pressure, and lipid panels to present a holistic view of disease progression and treatment responses. In heart failure cases, tools like echocardiogram-derived left-ventricular ejection fraction provide crucial insights into cardiac function and the efficacy of guideline-directed therapies.

In the oncology field, lab results serve to confirm diagnoses and offer prognostic insights vital for precision medicine. For patients dealing with neurological issues or rare diseases, EHR and clinical notes capture detailed information on symptoms, adverse events, and real-world outcomes, which traditional claims data cannot provide.

Accelerating Research and Evidence Generation



Andrew Kress, CEO of HealthVerity, stated, "With taXonomy Pathways, we are simplifying the assembly of longitudinal patient journeys. Now, researchers can seamlessly access claims, EHR, labs, and clinical notes in a single, research-ready framework that accelerates evidence generation without compromising rigor, privacy, or scale." This initiative stands as a potential game-changer in real-world evidence generation and safety assessments.

Among the features of taXonomy Pathways are lab results from two top outpatient labs that cover more than 60% of the U.S. testing market, including genetic assays. These results align with claims data timelines to establish baselines and analyze treatment responses effectively.

Additionally, real-world evidence (RWE) and health economic outcomes research (HEOR) teams can examine how often diagnostic tests lead to treatments and evaluate test outcomes by payer and geography, thus aiding market access strategies and provider engagement efforts.

To augment the insights provided, taXonomy Pathways also includes data from over 3.6 billion de-identified clinical notes from approximately 340 million encounters involving 43 million patients. These narratives offer a richer understanding of patient cases, encapsulating symptoms, disease severity, imaging results, contraindications, and reasons for treatment discontinuation. Such extensive insights far exceed what is typically available through a claims-only perspective.

Availability and Next Steps



taXonomy Pathways is officially available for use today. HealthVerity encourages interested parties to register for an upcoming webinar aimed at demonstrating how this innovative tool can help bridge evidence gaps in various therapeutic areas or to schedule direct consultations with their sales team.

About HealthVerity



HealthVerity is at the forefront of privacy-protected real-world data exchange, reshaping how healthcare and life sciences organizations connect and analyze disparate patient information. By facilitating access to the largest RWD ecosystem in the industry, HealthVerity supports essential functions in clinical development, commercial strategy, regulatory decision-making, and public health initiatives.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.